Maternal Hemodynamics at 11-13 Weeks' Gestation in Gestational Diabetes Mellitus

被引:18
|
作者
Khalil, Asma [2 ]
Garcia-Mandujano, Rosario [2 ]
Chiriac, Roxana [2 ]
Akolekar, Ranjit
Nicolaides, Kypros H. [1 ,2 ]
机构
[1] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, Dept Fetal Med, London SE5 9RS, England
[2] Univ Coll London Hosp, Inst Womens Hlth, Dept Fetal Med, London, England
关键词
Pregnancy; Gestational diabetes; Arterial stiffness; Pulse wave velocity; Central systolic blood pressure; ARTERIAL STIFFNESS; CARDIOVASCULAR-DISEASE; SERUM HOMOCYSTEINE; PREECLAMPSIA; PRESSURE; WOMEN; RISK; PREDICTION; MORTALITY; AUGMENTATION;
D O I
10.1159/000336692
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Women who develop gestational diabetes mellitus (GDM) are at increased risk of type 2 diabetes and subsequent cardiovascular mortality and morbidity. Individuals with cardiovascular disorders have increased central aortic systolic blood pressure (SBPAo) and arterial stiffness. The hypothesis of this study is that increased 5BP(Ao) and arterial stiffness are apparent before the development of GDM. Methods: In this screening study, SBPAo, pulse wave velocity (PWV) and augmentation index (Alx) were measured in women with singleton pregnancies attending for routine antenatal care at 11-13 weeks' gestation. We compared SBPA, PWV and Alx, expressed as multiples of the median (MoM), after adjustment for maternal characteristics affecting these measurements, in women who subsequently developed GDM (n = 105) with the values in non-GDM controls (n = 6,736). Results: In the GDM group, compared to non-GDM controls, there was an increase in PWV (1.04 MoM, interquartile range (IQR) 0.93-1.15 vs. 1.00 MoM, IQR 0.90-1.12; p = 0.0131 and SBPAo (1.03 MoM, IQR 0.98-1.14 vs. 1.00 MoM, IQR 0.94-1.08; p < 0.0001) but no significant difference in the Alx (1.02 MoM, IQR 0.89-1.22 vs. 1.00 MoM, IQR 0.87-1.17; p = 0.118). Conclusion: Women who develop GDM have increased SBPAo and arterial stiffness from the first trimester of pregnancy before the clinical onset of GDM. copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:216 / 220
页数:5
相关论文
共 50 条
  • [31] Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia
    Foidart, J. -M.
    Munaut, C.
    Chantraine, F.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2010, 35 (06) : 680 - 687
  • [32] Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation
    Tan, M. Y.
    Syngelaki, A.
    Poon, L. C.
    Rolnik, D. L.
    O'Gorman, N.
    Delgado, J. L.
    Akolekar, R.
    Konstantinidou, L.
    Tsavdaridou, M.
    Galeva, S.
    Ajdacka, U.
    Molina, F. S.
    Persico, N.
    Jani, J. C.
    Plasencia, W.
    Greco, E.
    Papaioannou, G.
    Wright, A.
    Wright, D.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2018, 52 (02) : 186 - 195
  • [33] Maternal serum placental growth factor at 11-13 weeks' gestation and fetal cardiac defects
    Llurba, E.
    Syngelaki, A.
    Sanchez, O.
    Carreras, E.
    Cabero, L.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 42 (02) : 169 - 174
  • [34] Screening for pre-eclampsia by maternal serum glycosylated fibronectin at 11-13 weeks' gestation
    Sokratous, N.
    Bednorz, M.
    Sarli, P.
    Montes, O. E. Morillo
    Syngelaki, A.
    Wright, A.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2023, 62 (04) : 504 - 511
  • [35] Maternal serum anti-Mullerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia
    Birdir, Cahit
    Fryze, Janina
    Vasiliadis, Haralambos
    Nicolaides, Kypros H.
    Poon, Leona C.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2015, 28 (7-8): : 865 - 868
  • [36] Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation
    O'Gorman, Neil
    Wright, David
    Syngelaki, Argyro
    Akolekar, Ranjit
    Wright, Alan
    Poon, Leona C.
    Nicolaides, Kypros H.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : 103.e1 - 103.e12
  • [37] Lateral ventricles in fetuses with aneuploidies at 11-13 weeks' gestation
    Loureiro, T.
    Ushakov, F.
    Maiz, N.
    Montenegro, N.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2012, 40 (03) : 282 - 287
  • [38] Correlation of nuchal translucency and thyroxine at 11-13 weeks of gestation
    Hantoushzadeh, Sedigheh
    Tara, Fatemeh
    Salmanian, Bahram
    Gharedaghi, Mohammad-Hadi
    Nasri, Khadijeh
    Ganjizadeh, Masoud
    Ghaffari, Saeed-Reza
    Tahmasebpour, Ahmad-Reza
    Farrokhi, Babak
    Abdollahi, Alireza
    Sheikh, Mahdi
    Javadian, Pouya
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2013, 26 (16): : 1586 - 1589
  • [39] Maternal cardiac function at 19-23 weeks' gestation in prediction of gestational diabetes mellitus
    Gibbone, E.
    Wright, A.
    Vallenas Campos, R.
    Anzoategui, S.
    Nicolaides, K. H.
    Charakida, M.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 58 (01) : 77 - 82
  • [40] Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation
    Poon, L. C. Y.
    Zymeri, N. A.
    Zamprakou, A.
    Syngelaki, A.
    Nicolaides, K. H.
    FETAL DIAGNOSIS AND THERAPY, 2012, 31 (01) : 42 - 48